ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 49

Perceptions of Methotrexate Intolerance in School-aged Children With Juvenile Idiopathic Arthritis

Charlene Hopper1, Sarah Khan2, Jacqueline Mancini2 and Janet Rennick3,4, 1Rheumatology, Montreal Children's Hospital McGill University Health Centre, Montreal, QC, Canada, 2Ingram School of Nursing, McGill University, Montreal, QC, Canada, 3Nursing, Montreal Children's Hospital McGill University Health Centre, Montreal, QC, Canada, 4Ingram School of Nursing and Department of Pediatrics, McGill University, Montreal, QC, Canada

Meeting: Pediatric Rheumatology Symposium 2017

Keywords: juvenile idiopathic arthritis (JIA), methotrexate (MTX), qualitative and quality of care

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Thursday, May 18, 2017

Title: Clinical and Therapeutic Poster Session

Session Type: Abstract Submissions

Session Time: 5:30PM-7:00PM

Background/Purpose:  Methotrexate (MTX) remains an effective and commonly used disease modifying anti-rheumatic drug (DMARD) for the treatment of Juvenile Idiopathic Arthritis (JIA). Approximately half of the children taking MTX will experience MTX intolerance, that is nausea, vomiting, anticipatory or associative nausea/vomiting. While we have information about MTX intolerance from the perspective of parents and older children, to date there are no studies focused on school-age children’s perception of MTX intolerance and its impact on daily life. School-age children have decisions made for them, however they remain experts of their own care and their input is essential for collaborative care and management. The purpose of this study was to explore school-age children’s perceptions of MTX intolerance, how MTX intolerance impacts their daily lives and how they manage MTX intolerance.

Methods: An interpretive descriptive design was used with purposive sampling to explore the perceptions of school-age children with JIA experiencing MTX intolerance. All children were interviewed using semi-structured interviews that incorporated a storyboard technique. The storyboard was in the shape of a house with 4 rooms. Children were provided with a variety of felt pieces depicting family members, pets, toys and furniture. Medical play items were also provided, including a syringe, needle, alcohol swab and pill bottle. The storyboard activity allowed the participants to begin to tell their stories about MTX intolerance by visually setting up and displaying their home environment, including the room in which they took their MTX, and to describe who was involved in their MTX administration. The storyboard facilitated the semi-structured interview in which children continued to describe their experience of MTX intolerance. Interview and observational data were collected and analyzed using qualitative inductive content analysis.

Results:  Twelve children, aged 6-12 years participated in the study. Interviews lasted an average of 35 minutes. All children enjoyed using the storyboard. Three themes were identified that captured the children’s experiences: (1) Children’s perceptions of methotrexate intolerance (including descriptions of anticipatory and associative nausea): “No kid likes taking methotrexate”. (2) Children’s strategies for managing MTX administration: ”When I’m going to take my MTX…I’m going down the stairs in slow motion”. (3) Working hard to live with MTX intolerance: “The next day, I’m happy because it’s another week” [before MTX again].

Conclusion: School-age children are able to clearly articulate their experience of MTX intolerance. Findings highlight the importance of exploring young children’s perceptions of intolerance when developing clinical strategies to manage care. Results will be used to explore more effective ways to prevent and manage MTX intolerance.


Disclosure: C. Hopper, None; S. Khan, None; J. Mancini, None; J. Rennick, None.

To cite this abstract in AMA style:

Hopper C, Khan S, Mancini J, Rennick J. Perceptions of Methotrexate Intolerance in School-aged Children With Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/perceptions-of-methotrexate-intolerance-in-school-aged-children-with-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to Pediatric Rheumatology Symposium 2017

ACR Meeting Abstracts - https://acrabstracts.org/abstract/perceptions-of-methotrexate-intolerance-in-school-aged-children-with-juvenile-idiopathic-arthritis/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology